NanoZolid®-formulated Docetaxel is Safe and Tolerable Showing Signs of Clinical Efficacy
04 oct. 2021 13h30 HE
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that no further patients will be enrolled in its dose escalating Phase I study (NZ-DTX-001) with the primary objective to study safety of...
LIDDS patent covering the NanoZolid® production process granted in Russia and Australia
28 sept. 2021 10h00 HE
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and hence achieved pharmaceutical products, has been granted in Russia...
LIDDS Interim report January – June 2021
26 août 2021 02h30 HE
|
LIDDS AB
JANUARY – JUNE 2021 Net sales amounted to MSEK 0.8 (0.0)Operating expenses amounted to MSEK -21.3 (-13.3)Profit/loss before and after tax amounted to MSEK -20.6 (-13.3)Earnings per share amounted...
LIDDS – subscription of warrants
06 juil. 2021 08h00 HE
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) The Annual General Meeting held on May 17, 2021, resolved to establish a warrants-based incentive programme 2021/2024 for the CEO and other key-persons in the...
LIDDS genomför en riktad nyemission av aktier och tillförs cirka 45 Mkr
02 juin 2021 16h00 HE
|
LIDDS AB
EJ FÖR DISTRIBUTION DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR...
LIDDS carry out a directed share issue of and is provided with approximately MSEK 45
02 juin 2021 16h00 HE
|
LIDDS AB
NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION...
LIDDS Announces Appointment of Jenni Björnulfson as New Chief Financial Officer
01 juin 2021 02h45 HE
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that Jenni Björnulfson has been appointed new Chief Financial Officer (CFO) of LIDDS AB succeeding Anja Peters, who will leave LIDDS at the end of...
LIDDS new CEO will present at Redeye’s Growth Day and Aktiespararna’s Småbolagsdagarna
28 mai 2021 02h45 HE
|
LIDDS AB
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that LIDDS new CEO Nina Herne will hold her first presentation at Redeye’s Growth Day on June 2 at 13.50 pm CET. To follow the event,...
LIDDS avser att genomföra en riktad nyemission av aktier om cirka 45 Mkr
27 mai 2021 16h20 HE
|
LIDDS AB
EJ FÖR DISTRIBUTION DIREKT ELLER INDIREKT, INOM ELLER TILL AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER USA, ELLER I NÅGON ANNAN JURISDIKTION DÄR...
LIDDS intends to carry out a directed share issue of approximately MSEK 45
27 mai 2021 16h20 HE
|
LIDDS AB
NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES, OR IN ANY OTHER JURISDICTION...